NEWS
Selected for the FY2025 “Innovation Promotion Project Toward Realizing Zero Emission Tokyo”
ProteoBridge Inc. (Head Office: Koto-ku, Tokyo; CE…
NEWS Index
A-Cube
Exhibiting at the 23rd Annual Meeting of the Japanese Society of Medical Oncology (JSMO 2026)
ProteoBridge Co., Ltd. is pleased to announce our …
NEWS
Naoki Goshima, Director, Executive Vice President and CSO of our company, will speak at the Biobank Utilization Seminar @ Ochanomizu.
Naoki Goshima, Director, Executive Vice President …
HuPEX
Announcement: The 1st HuPEX® Research Testing Information Seminar
We are pleased to announce that the 1st HuPEX® Res…
NEWS
Launch of the HuPEX® Comprehensive Protein Array Contract Analysis Service via Scientist.com
We have launched a contract analytical service for…
A-Cube
Explanation Video on a Study of Isolated Anti-SS-A Antibody Positivity in Systemic Sclerosis Using the A-Cube® Platform
Dr. Kazuki Matsuda, Assistant Professor and Chief …
A-Cube
35th A-Cube® Research Test Seminar Announcement
The 35th A-Cube® Research Test Seminar will be hel…
HuPEX
HuPEX®-Based Research Published in Nature Communications
Research conducted using HuPEX®, a comprehensive h…
NEWS
Notice of Year-End and New Year Holidays
Our office will be closed for the Year-End and New…
NEWS
Announcement of the Information Security Management System Certification
ProteoBridge Inc. is pleased to announce that we o…